Macrophage Repolarization as a Therapeutic Strategy for Osteosarcoma

Int J Mol Sci. 2023 Feb 2;24(3):2858. doi: 10.3390/ijms24032858.

Abstract

Macrophages are versatile immune cells and can adapt to both external stimuli and their surrounding environment. Macrophages are categorized into two major categories; M1 macrophages release pro-inflammatory cytokines and produce protective responses that lead to antimicrobial or antitumor activity. M2 or tumor-associated macrophages (TAM) release anti-inflammatory cytokines that support tumor growth, invasion capacity, and metastatic potential. Since macrophages can be re-polarized from an M2 to an M1 phenotype with a variety of strategies, this has emerged as an innovative anti-cancer approach. Osteosarcoma (OS) is a kind of bone cancer and consists of a complex niche, and immunotherapy is not very effective. Therefore, immediate attention to new strategies is required. We incorporated the recent studies that have used M2-M1 repolarization strategies in the aspect of treating OS cancer.

Keywords: M1 macrophage; M2 macrophage; TAM; TME; osteosarcoma; polarization; repolarization.

Publication types

  • Review

MeSH terms

  • Bone Neoplasms* / pathology
  • Bone Neoplasms* / therapy
  • Cytokines
  • Humans
  • Immunotherapy
  • Macrophages
  • Osteosarcoma* / pathology
  • Osteosarcoma* / therapy

Substances

  • Cytokines